EGF is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is PTD-DBM FDA approved?

PTD-DBM is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is EGF administered in research settings?

In research settings, EGF is typically administered via the topical, subcutaneous, or microneedling routes. PeptideBase does not provide dosing or administration instructions.

How is PTD-DBM administered in research settings?

In research settings, PTD-DBM is typically administered via the topical or intradermal routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›EGF vs PTD-DBM

Peptide Comparison

EGF vs PTD-DBM

Both are Skin & Cosmetic peptides.

EGF

Epidermal Growth Factor

Skin & JointNot EvaluatedResearch Only

No providers listed yet

Full EGF profile →

PTD-DBM

Wnt signaling activating peptide

Skin & JointNot EvaluatedResearch Only

7 providers listed

Full PTD-DBM profile →

Bottom line

EGF has published research citations on file; PTD-DBM does not yet — the main evidence gap between them.

Quick Verdict

EGF

Evidence

Observational

PTD-DBM

Evidence

Not rated

Which One Should You Choose?

Your goal	Better option
Has published research citations	EGF
More provider options (0 vs 7)	PTD-DBM

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

EGF

PTD-DBM

Mechanism Family

Skin & Cosmetic

Half-life

—

FDA Status

not evaluated

Admin Routes

topical, subcutaneous, microneedling

topical, intradermal

Availability

Research Only

Providers

None listed

7 listed

Research Evidence

EGF

ObservationalCohort study · 3 key studies · most recent 2026

PTD-DBM

No citations on file

Research Citations

EGF

Review2026 · Cell Tissue Bank

Determinants of extraction efficiency in human amniotic membrane processing: biological, mechanical, and bioc…

Cohort2026 · Gels

Development of Antiseptic and Epidermal Growth Factor Co-Loaded Thermoresponsive Composite Hydrogel for Wound…

Cohort2009 · International Wound Journal

The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary resu…

PTD-DBM

No citations on file.

About EGF

Binds EGFR (EGF receptor / ErbB1), activating RAS/MAPK and PI3K/Akt signaling cascades. Promotes keratinocyte and fibroblast proliferation, accelerates wound re-epithelialization, and stimulates collagen and hyaluronic acid production.

Research Areas

skin regenerationwound healingcollagen stimulationpost-procedure recovery

About PTD-DBM

Contains a protein transduction domain enabling intracellular delivery. Disrupts Dishevelled-Axin protein interaction, preventing β-catenin degradation and activating Wnt target genes essential for hair follicle cycling and new follicle neogenesis.

Research Areas

hair regenerationhair follicle activationWnt pathway modulationfollicle neogenesis

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

EGF

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

PTD-DBM

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Find Providers

Where to source these peptides

Providers offering

EGF

Browse directory →

Providers offering

PTD-DBM

7 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.